Log In
Print
BCIQ
Print
Print this Print this
 

Sustiva, efavirenz (DMP 266)

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionNon-nucleoside reverse transcriptase inhibitor (NNRTI)
Molecular Target Viral polymerase
Mechanism of ActionViral polymerase inhibitor
Latest Stage of DevelopmentMarketed
IndicationHIV / AIDS
Partner

Bristol-Myers Squibb Co.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today